Esomeprazole for Injection - Preferred Proton Pump Inhibitor
ProcurenetShort description
Ningbo Nuobai Pharmaceutical Co. Ltd presents ‘Esomeprazole for injection’, a widely used Active Pharmaceutical Ingredient (API). This product is crucial in the production of drugs to treat acid-related disorders. Key details include:
- Product Type: Active Pharmaceutical Ingredient (API)
- Usage: Used in drugs to reduce stomach acid and treat gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and other conditions involving excessive stomach acid.
- Application: Primarily used in the formulation of injectables.
- Support: The company offers thorough technical regulatory support to ensure the product complies with the relevant standards of pharmaceutical drug production.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Esomeprazole for injection is a proton pump inhibitor used in the medical field for managing conditions involving excessive gastric acid production. This product demonstrates an immense sales territory spanning across multiple continents like North America, Central/South America, Western Europe, Eastern Europe, Australasia, Asia, Middle East, and Africa.
Used mainly in the healthcare industry, Esomeprazole offers an effective treatment solution against diseases such as gastroesophageal reflux disease (GERD), ulcers, and Zollinger-Ellison syndrome. As a preferred choice in these therapeutic areas, Esomeprazole provides powerful control over gastric acid secretion by blocking the final step in its production, providing relief from symptoms and facilitating healing.
- Product Name: Esomeprazole for Injection
- IUPAC Name: (S)-5-methoxy-2-[(4-methoxy-3, 5-dimethylpyridin-2-yl) methylsulfinyl]-3H-benzoimidazole
- CAS Number: 161973-10-0
- Molecular Formula: C17H19N3O3S
- Molecular Weight: 345.42 g/mol
- Pharmacological Class: Proton Pump Inhibitor
- Sample Provided: No
- Payment Terms: L/L
Esomeprazole functions by inhibiting the H+/K+ ATPase in the gastric parietal cells, thereby suppressing basal and stimulated gastric acid secretion. Its dosage varies depending on the ailment being treated, and physicians should consider patient-specific factors like age, weight, and overall health status.
While Esomeprazole has proven its efficacy, contraindications do exist. Patients who are allergic to Esomeprazole or other benzimidazole derivatives should avoid its usage. Additionally, it should be used with caution in patients with severe liver impairment. Common side effects may include headache, nausea, stomach pain, or diarrhea. Always read the drug interactions before starting a course of Esomeprazole.
